Corporate News 09-Nov-23
Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
To fund acquisition of Biocon Biologics's Nephrology and Dermatology biz in India
Eris Lifesciences has availed a Term Loan Facility from Citi Bank N.A. amounting to Rs. 280 crore for financing the acquisition of the Nephrology and Dermatology businesses pertaining to the Indian Territory of Biocon Biologics as informed by the Company on 08 November 2023.
Previous News
Biocon announces board meeting date
( Corporate News - 04-Oct-24 09:29 )
Volumes spurt at Jubilant Ingrevia Ltd counter
( Hot Pursuit - 03-Oct-24 14:30 )
Biocon Biologics refinances debt through USD bonds and syndicated term loan
( Corporate News - 03-Oct-24 09:29 )
Biocon inks deal with Tabuk Pharma to commercialize GLP -1 products in Middle East
( Hot Pursuit - 27-Sep-24 11:03 )
Biocon signs licensing and supply agreement with Tabuk Pharmaceutical
( Corporate News - 26-Sep-24 19:00 )
Biocon Ltd up for third consecutive session
( Hot Pursuit - 11-Sep-24 13:06 )
Biocon arm gets USFDA nod for chronic heart failure drug
( Hot Pursuit - 02-Sep-24 08:59 )
Biocon arm inks pact to launch biosimilar Bmab 1200 in multiple countries
( Hot Pursuit - 29-Aug-24 12:21 )
Biocon Biologics signs settlement and license agreement with Janssen
( Corporate News - 29-Aug-24 09:03 )
Biocon Ltd up for fifth session
( Hot Pursuit - 22-Aug-24 13:00 )
Biocon Ltd rises for third consecutive session
( Hot Pursuit - 20-Aug-24 13:05 )
Other Stories
RACL Geartech receives ratings action from CARE
05-Oct-24 14:24
JHS Svendgaard Retail Ventures EGM scheduled
05-Oct-24 13:50
Lexus Granito (India) EGM scheduled
05-Oct-24 13:50
Latteys Industries EGM scheduled
05-Oct-24 13:50
Embassy Office Parks REIT to convene board meeting
05-Oct-24 13:50
Board of Fusion Micro Finance appoints director
05-Oct-24 13:17
Board of Fusion Micro Finance approves rights issue of Rs 550 cr
05-Oct-24 13:15
Bharti Airtel deploys additional spectrum in Jammu-Kashmir & Leh Ladakh
05-Oct-24 12:53
Dr Reddys announces incorporation of new step-down subsidiary in Denmark
05-Oct-24 11:37
360 ONE WAM grants 21.47 lakh stock options
05-Oct-24 11:32
Back
Top
